Beacon Pointe Advisors, LLC Illumina, Inc. Transaction History

Beacon Pointe Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$187.24 - $242.74 $42,129 - $54,616	-225 Reduced 14.21%	1,358 $274,000
Q3 2022 Nov 09, 2022	BUY	$177.23 - $227.44 $18,077 - $23,198	102 Added 6.89%	1,583 $304,000
Q2 2022 Aug 11, 2022	SELL	$181.58 - $368.0 $1.05 Million - $2.13 Million	-5,795 Reduced 79.65%	1,481 $270,000
Q1 2022 May 17, 2022	BUY	$303.87 - $423.8 $1.64 Million - $2.29 Million	5,403 Added 288.47%	7,276 $2.54 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $18,405 - $22,356	53 Added 2.91%	1,873 $713,000
Q3 2021 Nov 15, 2021	SELL	$405.61 - $524.84 $138,718 - $179,495	-342 Reduced 15.82%	1,820 $738,000
Q2 2021 Aug 17, 2021	BUY	$372.84 - $481.5 $806,080 - $1.04 Million	2,162 New	2,162 $1.02 Million

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.